REGULATORY AGENCY ACTION
more information on the effects of AB
2929, see CRLR Vol. 7, No. 2 (Spring
1987) p. 64 and Vol. 7, No. 1 (Winter
1987) p. 56.)
The Bureau's primary objective is to
limit abuses among those firms which
place individuals in a variety of employment positions. It prepares and administers a licensing examination and issues
several types of licenses upon fulfillment
of the Bureau's requirements.
The Bureau is assisted by an Advisory
Board created by the Employment Agency Act. This seven-member Board consists of three representatives from the
employment agency industry and four
public members. All members are appointed for a term of four years. As of
this writing, seats for one public and
two industry members remain vacant.
MAJOR PROJECTS:
Regulations Approved. On May 9,
the Office of Administrative Law approved several proposed regulatory
changes which were the subject of a
January 8 public hearing. (See CRLR
Vol. 8, No. 1 (Winter 1988) p. 68 for a
complete description of the proposed
changes.) Included in the approved package are the Bureau's citation and fine
regulations, adopted pursuant to section
125.9 of the Business and Professions
Code.
Pilot Enforcement Program. The
Bureau is continuing to declare its pilot
enforcement program a success. (For
background information, see CRLR Vol.
8, No. 2 (Spring 1988) p. 7; Vol. 8, No.
1 (Winter 1988) p. 68; and Vol. 7, No. 4
(Fall 1987) p. 63.) During the 1987-88
fiscal year, the Bureau received a higher
number of complaints than in the preceding year. In early May, the Bureau
turned one of its investigations over to
the Federal Trade Commission, resulting
in the closure of Overseas Unlimited
Agency, a Los Angeles-based computerized job-matching service. The Bureau's
enforcement program has also resulted
in the recent transfer of six investigations of job listing services to the Attorney General's Office for prosecution.
LEGISLATION:
AB 4554 (Roybal-Allard) would require foreign labor agents who find
employment for temporary foreign workers to be licensed by the state. This bill
passed the Assembly on May 19 and is
pending in the Senate Business and Professions Committee.
AB 4638 (Quackenbush), which failed
passage in the Assembly Ways and
Means Committee on June 1, would
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have established a separate category for
career counselors; required the Bureau
to administer a specialized exam for
such persons; and established criteria
for applicant eligibility.
SB 2471 (Montoya). Existing law
provides that if a nurses' registry collects
a fee or expenses for an assignment
from a nurse and the nurse fails to
obtain the assignment or the nurse fails
to be paid for the assignment, the nurses'
registry shall repay the fee or expenses
collected. This bill would provide that
any person who successfully brings an
action to enforce that provision shall
also be awarded attorney fees and costs.
This bill is pending in the Senate Business and Professions Committee.
The following is a status update on
measures reported in detail in CRLR
Vol. 8, No. 2 (Spring 1988) at page 72:
AB 4007 (Lancaster), the Department of Consumer Affairs' 1988 omnibus
bill, would delete specified categories of
employment agencies from the Business
and Professions Code, thus requiring
those agencies to obtain a general license
from the Bureau. The bill passed the
Assembly on May 19 and is pending in
the Senate Business and Professions
Committee.
AB 4145 (Wright). Existing law requires the contract for employment counseling services to state the amount of the
fee charged to the consumer. This bill
would require that the fee be stated for
each service received. This bill would
also require that a contract provided by
a licensee to a jobseeker contain a statement that the licensee will provide a
minimum of three job opportunities;
specify requirements for fee refunds; and
exempt from the Employment Agency
Law any employment counseling service
which provides services strictly on an
hourly basis, with no financial obligation to the consumer beyond the hourly
fees for services rendered. AB 4145
passed the Assembly on June 20 and is
pending in the Senate Business and Professions Committee, where it is scheduled
for an August hearing. At this writing,
according to Assemblymember Wright's
office, the Department of Consumer
Affairs is working with the author on
amendments to the measure which might
effectively abolish the Bureau.
FUTURE MEETINGS:
To be announced.
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BOARD OF PHARMACY
Executive Officer: Lorie G. Rice
(916) 445-5014
The Board of Pharmacy grants licenses and permits to pharmacists, pharmacies, drug manufacturers, wholesalers
and sellers of hypodermic needles. It
regulates all sales of dangerous drugs,
controlled substances and poisons. To
enforce its regulations, the Board employs full-time inspectors who investigate
accusations and complaints received by
the Board. Investigations may be conducted openly or covertly as the situation demands.
The Board conducts fact-finding and
disciplinary hearings and is authorized
by law to suspend or revoke licenses or
permits for a variety of reasons, including professional misconduct and any acts
substantially related to the practice of
pharmacy.
The Board consists of ten members,
three of whom are public. The remaining
members are pharmacists, five of whom
must be active practitioners. All are appointed for four-year terms.
MAJOR PROJECTS:
Continuing Education Regulations.
At its April 6 meeting in Los Angeles,
the Board held a public hearing on proposed changes to its complex continuing
education (CE) regulations, which appear in Chapter 17, Title 16 of the California Code of Regulations (CCR). (See
CRLR Vol. 8, No. 2 (Spring 1988) p. 73
and Vol. 8, No. 1 (Winter 1988) pp. 6869 for background information and a
detailed description of the proposed
changes.)
After Continuing Education Committee Chair Glenn Yokoyama summarized the changes, the Board entertained
several industry comments and suggestions for amendments. The Board adopted amendments proposed that day to
the language of section 1732.3(c) regarding the length of time a recognized CE
provider's coursework shall be valid following initial presentation; and section
1732.3(d) regarding required contents of
CE providers' advertisements of their
CE courses. The Board also voted to
add a provision regarding the Board's
authority to assign CE hours to inspectors and Board members for certain
presentations.
Following its approval of these
changes, the Board voted to adopt the
proposed CE regulation changes as
amended. The regulatory package was
submitted to the Office of Administrative Law (OAL) on May 27.
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Fee Increases. Also on April 6, the
Board held a public hearing on its proposal to amend section 1749, Chapter
17, Title 16 of the CCR, to increase its
many licensure fees. (See CRLR Vol. 8,
No. 2 (Spring 1988) p. 74 for background
information.) The increased fees were
already being collected through legislative authority granted in SB 79 (Chapter 657, Statutes of 1987), and the Board
desired to conform its regulations with
the statute. With two clarifications to
the language of the proposed regulations
(the delinquent renewal wholesalers' and
out-of-state distributors' penalty fee is
$150; and the new exemptee license fee
is $110), the Board adopted the proposed
amendments to section 1749, and planned to submit them to the OAL in
mid-July.
Rule Change Approved. On May 10,
the OAL approved the Board's proposed
amendments to section 1717(a) of its
regulations, concerning reuse of clean
containers in a licensed health facility
for non-liquid oral products; and section 1718.1, regarding the distribution
of drugs not bearing a manufacturer's
expiration date. (See CRLR Vol. 8, No.
2 (Spring 1988) p. 73 and Vol. 8, No. 1
(Winter 1988) p. 69 for background information.)
LEGISLATION:
SB 2731 (Campbell) would exempt
from the definition of "manufacturer" a
pharmacy which compounds a drug for
parenteral therapy, pursuant to a prescription, for delivery to another person
licensed to possess that drug. The bill
would also require a pharmacy which
compounds a drug for another pursuant
to the above provision to report that
information to the Board of Pharmacy
within thirty days. This bill is pending
in the Assembly Health Committee.
AB 513 (Hill), as amended on June
2, would except from the definition of
"manufacturer" a pharmacy compounding a drug for parenteral therapy, pursuant to a prescription, for delivery to
another pharmacy for delivering or
administering the drug to a prescription
patient. The bill would also require a
pharmacy compounding a drug pursuant
to that provision to report that information to the Board within thirty days
of commencing that compounding. This
bill has passed both houses and is pending in conference committee at this
writing.
SB 2469 (Dills), as amended on May
12, would prohibit disposal of a hypodermic needle or syringe in any public
place or area unless in a container
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rendering it safe from an accidental cutting or sticking. This bill, which is pending in the Assembly Health Committee,
would exempt the disposal of syringes
or needles in a private home or health
care facility.
SB 2213 (Craven), as amended on
April 21, would require any pharmacy
located outside California which ships,
mails, or delivers any controlled substances or dangerous drugs or devices
into California to register with the
Board, disclose specified information to
the Board, and meet other conditions.
The bill would also authorize the Board
to deny, revoke, or suspend a nonresident pharmacy registration for failure to
comply with specified provisions of California law and for conduct which causes
serious bodily or psychological injury to
a California resident if the regulatory
agency in the state where the pharmacy
is located fails to initiate an investigation into the matter within 45 days of
being notified by the Board. Finally, the
bill would prohibit specified advertisements with regard to unregistered, nonresident pharmacies. SB 2213 is pending
in the Assembly Health Committee.
AB 3578 (Moore), as amended on
April 18, would allow licensed drug
wholesalers to sell hypodermic syringes
and needles without a permit. The bill
would also add licensee incompetence,
fraud, and deceit as grounds for discipline by the Board, and would allow the
Board to recover its investigative and
prosecutorial costs in certain cases. The
bill also specifies that existing law prohibiting delivery of certain controlled
substances to a pharmacy unless a receipt
for the merchandise is signed by a pharmacist shall not require a common carrier to label packages in a manner
contrary to any federal law or regulation.
AB 3578 passed the Assembly on June
9, and is awaiting committee assignment
in the Senate at this writing.
AB 2683 (Hughes), as amended on
January 21, would prohibit the manufacture, packaging, sale, furnishing, or
distribution of prophylactics which fail
to conform to standards adopted by the
Department of Health Services, and
would require the Department to adopt
those standards. This bill is pending in
the Senate Health and Human Services
Committee.
AB 1732 (Isenberg), as amended on
May 31, would specifically prohibit persons authorized to prescribe or write a
prescription, with the exception of specified clinics, veterinarians, programs,
and certain prescribers, from dispensing
drugs to patients in his/her office or

place of practice unless specified conditions are met, and would prohibit the
person from charging a patient more
than the prescriber's acquisition cost of
the drug product plus 5% for overhead
expenses. AB 1732 would also require
the Board of Medical Quality Assurance
(BMQA) to notify the Board of Pharmacy of the receipt of a complaint relating to serious bodily injury due to
drugs dispensed by a prescriber, and
would require BMQA to investigate the
complaint within thirty days. This bill is
pending in the Senate Business and Professions Committee.
AB 2374 (Statham), as amended on
May 26, would divert $50 (out of fines
and forfeitures collected in municipal
and justice courts) for each conviction
for offenses related to possession, use,
or being under the influence of specified
controlled substances; possession or sale
of hypodermic needles or syringes; rape;
and sodomy. The money would be deposited in a special account in the
county treasury to pay for the reasonable costs of establishing and providing
an AIDS education program. The program would apply, as a condition of
either a sentence of probation or participation in a drug diversion program,
to a person pleading guilty to or convicted of any of the crimes described
above (except rape and sodomy). This
bill is pending in the Senate Appropriations Committee.
AB 3127 (Areias) would require triplicate prescription blanks to have the
federal registry number for controlled
substances preprinted thereon, and would
also amend the routing process for certain prescriptions of controlled substances. This bill is pending in the Senate
Judiciary Committee.
AB 3766 (Connelly), as amended on
June 9, would authorize courts to order
medical practitioners charged with a felony violation of specified controlled substance laws to surrender all triplicate
prescription blanks in the practitioner's
possession. This bill passed the Assembly
on June 9 and is awaiting Senate committee assignment at this writing.
AB 4499 (Felando) would authorize
a pharmacist to substitute a generically
equivalent drug for a prescribed drug
only if it is listed as having a "Code A"
by the federal Food and Drug Administration; if it has a "Code B", the pharmacist must obtain authorization from the
prescriber prior to substitution. This bill
has been pending in the Assembly Health
Committee since March 7.
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RECENT MEETINGS:
At its January meeting in Monterey,
the Credentials Committee requested
Board approval of guidelines it had formulated regarding consideration of time
worked as a pharmacist in a foreign
country toward the 1,500-hour internship
experience requirement. Because the
Board's internship regulation (section
1728) does not specify criteria for acceptance of pharmacist experience obtained outside the United States, the
Board approved the following guidelines
for the Committee's use in considering
up to 600 hours of foreign graduate
intern experience:
-certain types of experience, including
pharmacy technician, teaching, and research, will be excluded from consideration;
-the Committee will consider the request for credit for experience only if
the individual has a valid California
intern registration and has completed
250 intern hours;
-the full 600 hours must be obtained
after graduation from pharmacy school;
-the experience must have been obtained within the last three years prior
to the request for credit;
-the hours must have been obtained
in a country where practice is essentially
the same as in the United States; and
-documents and/or affidavits provided on behalf of the applicant must
meet specified requirements.
Also at its January meeting, the
Board approved an amendment to its
disciplinary guidelines. The previous rule
barred pharmacists on probation from
serving as pharmacists-in-charge; this
guideline, however, precluded probationers who own a one-person pharmacy
from being his/her own pharmacist-incharge. The Board adopted an amendment which provides that in appropriate
cases, in lieu of the standard provision
barring a probationer from being a
pharmacist-in-charge, the pharmacist
may be required to retain a consultant
at his/her own expense, who shall be a
licensed California pharmacist, approved
by the Board, and not on probation.
The consultant pharmacist would be responsible for review of the pharmacy
operations for compliance with federal
and state statutes and regulations.
At its April meeting in Los Angeles,
Maureen Whitmore, Program Director
of Occupational Health Services, Inc.,
presented a status report on the Board's
Impaired Pharmacists' Program. The
three objectives of the program include
protection of the public; assisting impaired pharmacists in the early stages of
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a substance/alcohol abuse problem; and
offering impaired pharmacists a nonpunitive, confidential environment. Thus
far, 139 pharmacists has participated in
the program since its inception. The
Board discussed the fact that substanceabuse-related "down-time" (that is, suspension of the pharmacist's license) is
often imposed after the impaired individual has begun to participate in the program and has made substantial improvement, but was reminded that the purpose
of the program is not punishment but
protection of the public.
Also at its April meeting, the Board
reviewed and adopted twelve goals and
objectives for the next three years, which
include the following: development and
implementation of pharmacy technician
regulations; implementation of a new
automated data processing system to increase efficiency of licensing and enforcement operations; increasing consumer
protection by implementing recent legislation regarding legend drugs and/or
devices, and by increasing liaison activities with consumer groups through participating in meetings, newsletters, and
public forums; and reviewing the appropriateness of the current hypodermic
statute in light of the AIDS epidemic.
FUTURE MEETINGS:
October 12-13 in Anaheim.
January 12-13, 1989 in San Diego.
March 15-16, 1989 in Sacramento.

POLYGRAPH EXAMINERS
BOARD
Executive Officer: Dia Goode
(916) 739-3855
The Polygraph Examiners Board
operates within the Department of Consumer Affairs. The Board has authority
to issue new licenses and to regulate the
activities of an estimated 655 examiners
currently licensed in California under
Business and Professions Code section
9300 et seq. The Board has no jurisdiction over federally-employed polygraph examiners.
The Polygraph Examiners Board
consists of two industry representatives
and three public members, all appointed
to four-year terms. The Board has a
sunset date of January 1, 1990.
MAJOR PROJECTS:
Enforcement. An administrative law
judge (ALJ) has ruled against a San
Pablo polygraph examiner in a case involving the respondent's administration
of a polygraph test to a sixteen-year-old
who was suspected of stealing from his
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employer.
The polygraph examiner, Alan Barr
Donnelly, administered the exam to the
youth in July 1985. During that same
month, Donnelly applied for licensure
with the Board. Following an investigation into complaints surrounding Donnelly's examination of the youth, the
Board denied his application in November 1986, citing numerous violations of
state laws governing polygraph examiners. Donnelly immediately appealed.
In upholding the Board's denial of
Donnelly's license, the ALJ's May 19
decision included findings supporting
Board allegations that Donnelly (1)
negligently misinterpreted test results;
(2) mishandled the pre-test of the youth
(that is, questioning before administration of the actual test for purposes of
framing control questions and providing
an opportunity to observe the examinee
and his reactions to questions) by asking
questions which "far exceeded the appropriate scope for a specific examination
involving theft"; (3) "coerced and threatened [the examinee] to induce him to
consent to a warrantless search" of the
youth's bedroom and his father's home;
and (4) misrepresented his background
and professional standing to the examinee and the youth's parents.
Observing that "the facts of the case
herein point to either lack of awareness
or blatant disregard for the standards of
practice for a polygraph examiner," the
ALJ ordered that Donnelly's application
for licensure be denied.
This case represents the first time a
Board enforcement case has been heard
before an administrative law judge.
LEGISLATION:
SB 2219 (Dills) passed the Senate on
May 9 on a 34-0 vote and was referred
to the Assembly, where it was amended
on June 9. The bill would provide that
if a license is renewed more than thirty
days after its expiration, the licenseholder, as a condition precedent to renewal, shall also pay a specified delinquency
fee. A Board-proposed amendment to
SB 2219 would permit the Board to
recover the costs of investigating and
prosecuting disciplinary matters. The
amendment would also allow the Board
to prorate the costs of license upgrading.
SB 2219 passed the Assembly Committee
on Governmental Efficiency and Consumer Protection on June 23.
SB 2220 (Dills) died before it was
heard in a Senate committee. The bill
was an effort to delete the statutory
requirement that the Board must pay
back a $50,000 loan from the General

